l carnitine and chronic kidney disease

l carnitine and chronic kidney disease metabolic disorders novel clinical approaches: Mechanistic insights from deficiency management to liver and treatment Carnitine dysregulation in diabetic kidney

Name: l carnitine and chronic kidney disease metabolic disorders novel clinical approaches: Mechanistic insights from deficiency management to liver and treatment Carnitine dysregulation in diabetic kidney
Brand: centoria.fr
SKU: 68543870958
Price: 20.04 USD
Availability: InStock
Rating: 4.495900000000001 (12 reviews)

Carnitine dysregulation in diabetic kidney disease: from pathogenic mechanism to precision biomarker Journal of Translational Medicine Springer Nature Link Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia: iScience History of L carnitine: Implications for renal disease Journal of Renal Nutrition Carnitine: Genetic Variants Affecting Mitochondrial Energy and Health

SKU: 68543870958 · From centoria.fr

4.5

USD20.04 USD60.04

Pay in 4 interest-free payments of $5.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 26 - Oct 1

Description

Research purposes only, Not for human consumption

The anoctamin 1 (ANO1/TMEM16A) protein (also known as DOG1) is a marker protein for gastrointestinal stromal tumors, and its role in cell proliferation and development of different types of malignant tumors has been extensively reported